The EU welcomes the considerable progress made in the accessibility of antiretroviral treatment (ARV), but notes with concern the uneven treatment coverage between regions.
EL tervitab märkimisväärseid edusamme retroviirusevastane ravi osas, kuid märgib murega ravi ebaühtlast hõlmavust erinevates piirkondades.